Hyperion Notified That FDA Will Not Meet the PDUFA Action Date for Ravicti(TM)

[at noodls] – SOUTH SAN FRANCISCO, Calif., Jan. 16, 2013 (GLOBE NEWSWIRE) — Hyperion Therapeutics, Inc. (Nasdaq:HPTX) said that the U.S. Food and Drug Administration (FDA) has advised the Company not to expect a final … more

View todays social media effects on HPTX

View the latest stocks trending across Twitter. Click to view dashboard

See who Hyperion is hiring next, click here to view